Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock ...

WASHINGTON–A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate ...

Despite progress with the SCAI SHOCK Classification, introduced in 2019 and updated in 2022, clinicians still require a reliable method to track treatment effectiveness in real-time, helping them ...

The first FDA-approved automated tool that classifies and tracks cardiogenic shock provides patient data in real time, helping clinicians see information that’s often unrecognized and to quickly ...